טוען...
A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation
In January 2003, a 55-year old, non-smoking woman visited our hospital to undergo treatment for T4N0M0 pulmonary adenocarcinoma of the left lung. Until death in October 2015, she received over 20 lines of treatment including a second line therapy with gefitinib, which showed long response. In March...
שמור ב:
| הוצא לאור ב: | Respir Med Case Rep |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053035/ https://ncbi.nlm.nih.gov/pubmed/27747151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2016.09.002 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|